ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 247

$756K Total Retail Price of All Prescriptions

Rank: 8 out of 247

515 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 515 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 515 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 10,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 637 558 1 1
METOPROLOL TARTRATE 584 518 2 7
LISINOPRIL 486 411 3 2
LEVOTHYROXINE SODIUM 462 392 4 3
OMEPRAZOLE 413 319 5 4
HYDROCODONE-ACETAMINOPHEN 408 243 S3 6 11
AMLODIPINE BESYLATE 368 342 7 6
FUROSEMIDE 341 277 8 5
METFORMIN HCL 289 235 9 12
WARFARIN SODIUM 262 241 10 13
ATORVASTATIN CALCIUM 222 205 11 8
HYDROCHLOROTHIAZIDE 218 194 12 9
METOPROLOL SUCCINATE 208 170 13 14
ZOLPIDEM TARTRATE 198 142 14 24
LOSARTAN POTASSIUM 197 183 15 15
GABAPENTIN 197 128 15 17
CITALOPRAM HBR 186 145 17 20
SERTRALINE HCL 170 102 18 16
PANTOPRAZOLE SODIUM 159 135 19 19
TRIAMTERENE-HCTZ 151 139 20 67
LOVASTATIN 145 109 21 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 105 22 51
OXYCODONE-ACETAMINOPHEN 129 51 S2 23 87
GLIPIZIDE 121 99 24 43
TRAMADOL HCL 120 87 25 25
ISOSORBIDE MONONITRATE ER 119 103 26 40
POTASSIUM CHLORIDE 113 106 27 36
TRAZODONE HCL 109 74 28 28
ATENOLOL 102 96 29 10
CRESTOR 96 83 30 30
KLOR-CON M10 96 66 30 95
MIRTAZAPINE 93 58 32 46
ADVAIR DISKUS 91 73 33 18
PRAVASTATIN SODIUM 89 89 34 23
ALLOPURINOL 89 74 34 33
LIPITOR 89 65 34 50
PROAIR HFA 87 62 37 29
ALENDRONATE SODIUM 87 78 37 32
GLYBURIDE 83 83 R 39 41
CARVEDILOL 80 62 40 59
PREDNISONE 78 67 41 21
OXYCODONE HCL 75 34 S2 42 27
COMBIVENT 75 61 42 63
LANTUS 71 50 44 39
SPIRIVA 71 61 44 26
FLUTICASONE PROPIONATE 69 60 46 37
FENTANYL 65 53 S2 47 72
VENLAFAXINE HCL ER 64 51 48 64
ESCITALOPRAM OXALATE 62 36 49 65
PRAMIPEXOLE DIHYDROCHLORIDE 59 43 50 123
RANITIDINE HCL 58 40 51 34
AMITRIPTYLINE HCL 57 35 R 52 55
MECLIZINE HCL 55 53 53 151
LYRICA 55 28 53 118
PAROXETINE HCL 54 54 55 45
CHLORTHALIDONE 54 43 55 98
FELODIPINE ER 53 53 57 127
GLIPIZIDE ER 53 30 57 134
KLOR-CON 10 50 50 59 103
OXYCODONE HCL-ACETAMINOPHEN 50 26 S2 59 233
DIOVAN 50 48 59 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.